ghk-cu clinical trial oral Scalp Solution Copper Peptide Before and After:

A 2025 systematic review analyzing this data reported that 7 of 12 patients maintained symptom improvement beyond 6 months

Technical Specifications Compound: Glycyl-L-Histidyl-L-Lysine Copper Complex (GHK-Cu) Format: Lyophilized peptide Strength: 50 mg per vial Purity: 9899% (COA included) Appearance: Blue-hued lyophilized powder Category: Research reagent (non-clinical) Intended Use This product is intended exclusively for: Laboratory research In-vitro experimentation Biochemical and molecular assays Mechanistic pathway studies Preclinical, non-human model exploration Institutional or academic research programs Not intended for: Human or veterinary consumption Cosmetic or dermatological use Injection, ingestion, inhalation, or topical use Medical, therapeutic, or clinical applications This material is not approved by Health Canada, FDA, or any regulatory authority for clinical use

However, you would lose the potential B12 supplementation benefits

However, a recent in vitro study showed that crotalphin might reduce cell viability in primary neuronal cultures [210], which could restrict its clinical applicability

Whats risky about peptides